ALCNYSEOphthalmic GoodsUS GAAP · USD

Alcon Inc

Alcon Inc is a United States-based ophthalmic goods company focused on eye care products and surgical ophthalmology solutions. Its business is organized around two global segments, Surgical and Vision Care, serving eye surgeons, eye-care professionals, and consumers through a broad portfolio of devices, consumables, contact lenses, and ocular health products.

Liikevaihto10,4mrd USD
+4,9 %v/v
Liikevoitto (EBIT)1 364milj. USD
−5,8 %v/v
EBIT-marginaali13,1%
−1,5 %-yks.v/v
Nettotulos980milj. USD
−3,7 %v/v
Vapaa kassavirta1 608milj. USD
+14,3 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2022–2025

0,02,55,07,510,012,5mrd USD2022: 8,7 mrd USD2022: EBIT 0,60 mrd USD20222023: 9,5 mrd USD2023: EBIT 1,0 mrd USD20232024: 9,9 mrd USD2024: EBIT 1,4 mrd USD20242025: 10,4 mrd USD2025: EBIT 1,4 mrd USD202510,41,4
LiikevaihtoLiikevoitto (EBIT)

Liiketoiminta

Osuus liikevaihdosta
Surgical ophthalmology50 %

Devices, implants, consumables and equipment used in eye surgery.

Contact lenses35 %

Daily disposable, reusable and color-enhancing lenses for vision correction.

Ocular health products12 %

Over-the-counter and prescription products for eye surface and lens care.

Cell therapies3 %

Therapies developed to treat ocular diseases.

Asiakkaat

Alcon sells to ophthalmic surgeons, hospitals, ambulatory surgery centers, eye-care professionals and optical channels that prescribe or dispense its products. It also sells consumer-oriented vision care products through retail and professional distribution channels, making its customer base a mix of procedural, clinical and end-user buyers.

Ophthalmic surgeons

Buy surgical systems, implants and consumables used in cataract, retinal and glaucoma procedures.

Hospitals and ambulatory surgery centers

Purchase surgical equipment, procedure packs and related disposables for ophthalmic operations.

Eye-care professionals

Recommend and dispense contact lenses and ocular health products for patient care.

Retail and optical channels

Stock contact lenses and eye care products for broad consumer access.

Consumers and patients

Use lenses, OTC ocular health products and therapies for vision correction and eye comfort.

Strategia

Alcon’s strategy is built around two complementary platforms: surgery for procedural ophthalmology and vision care for lenses and ocular health. Its priorities center on broadening the product portfolio, supporting end-to-end eye care workflows and using global scale in research, manufacturing and distribution to serve both professional and consumer channels.

Expand the surgical eye-care platformKeskipitkä aikaväli

Broadening procedure coverage can deepen surgeon relationships and increase share of operating-room spend.

Grow vision care and ocular healthKeskipitkä aikaväli

Recurring contact lens and eye-health purchases can stabilize demand and widen the customer base.

Maintain global operating scalePitkä aikaväli

Worldwide manufacturing, distribution and commercial execution are central to serving fragmented eye-care markets.

Maantiede

Alcon operates on a worldwide basis, with its segments managed globally across research, manufacturing, distribution and commercial execution. The company’s performance is therefore tied to international ophthalmology demand, local reimbursement and healthcare access, and the ability to serve clinicians and consumers across multiple regions.

Riskit

Alcon faces the usual ophthalmic-device risks around product adoption, procedure volumes, pricing and competition, plus execution risk from its global supply, manufacturing and commercial network. The company also carries meaningful report-based risks from acquired intangible assets and investments, where impairment judgments and fair value changes can materially affect reported results.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Goodwill and intangible asset impairment1Elective surgery demand volatility2Product and pricing competition3Global execution and supply chain complexity4
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Goodwill and intangible asset impairmentVaikutus: KorkeaTodennäköisyys: Kohtalainen

    The company states goodwill, brand name and IPR&D are significant and tested for recoverability, creating potential large non-cash charges.

    KohdistuuGoodwillBrand nameAcquired IPR&D
  2. Elective surgery demand volatilityVaikutus: KorkeaTodennäköisyys: Kohtalainen

    A meaningful part of Surgical depends on procedure volumes for cataract, refractive and glaucoma surgery.

    Kohdistuu: Surgical segment

  3. Product and pricing competitionVaikutus: KeskitasoTodennäköisyys: Korkea

    The eye-care and contact lens markets are competitive and require continued innovation and commercial execution.

    Kohdistuu: Surgical and Vision Care

  4. Global execution and supply chain complexityVaikutus: KeskitasoTodennäköisyys: Korkea

    Worldwide research, manufacturing and distribution increase exposure to operational disruption.

    Kohdistuu: Global operations

Kirjanpito

Harkinnanvaraiset erät
Goodwill and intangible impairment

Annual and trigger-based impairment tests can create sizable non-cash charges if segment cash flows weaken.

Vaikutus: Could materially affect operating results and balance sheet carrying values

Equity-method investments

Share of loss or gain from associated companies affects reported earnings even when cash flow is limited.

Vaikutus: Can introduce period-to-period volatility

Fair value remeasurements

Remeasurement gains on investments can distort underlying operating performance.

Vaikutus: Affects non-operating income and comparability

IFRS estimates and assumptions

Management estimates influence asset values, liabilities and expense timing.

Vaikutus: Can affect comparability across periods

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Päivitetty: 28.9.2026